PPAR&ggr; Agonists Attenuate Trigeminal Neuropathic Pain

No abstract is available for this paper.

• Publication year

  2017

• Venue

  The Clinical Journal of Pain

• Publication date

  2017-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/AJP.0000000000000509PMID 28514232PMCID PMC5675763
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• TRPA1 mediates trigeminal neuropathic pain in mice downstream of monocytes/macrophages and oxidative stress.

  2016cited by this paper
• Reference Gene Selection for Quantitative Real-time PCR Normalization in Caragana intermedia under Different Abiotic Stress Conditions

  2013cited by this paper
• Sensory cortex limits cortical maps and drives top-down plasticity in thalamocortical circuits

  2013cited by this paper
• Targeting PPAR isoforms following CNS injury.

  2013cited by this paper
• PPARγ activation blocks development and reduces established neuropathic pain in rats.

  2013cited by this paper
• The Role of Peroxisome Proliferator-Activated Receptor and Effects of Its Agonist, Pioglitazone, on a Rat Model of Optic Nerve Crush: PPARγ in Retinal Neuroprotection

  2013cited by this paper
• Differential diagnosis of facial pain and guidelines for management.

  2013cited by this paper
• Anti-inflammatory and anti-hyperalgesic effect of all-trans retinoic acid in carrageenan-induced paw edema in Wistar rats: Involvement of peroxisome proliferator-activated receptor-β/δ receptors

  2013cited by this paper
• Orofacial neuropathic pain mouse model induced by Trigeminal Inflammatory Compression (TIC) of the infraorbital nerve

  2012cited by this paper
• The PPAR-gamma agonist pioglitazone protects cortical neurons from inflammatory mediators via improvement in peroxisomal function

  2012cited by this paper
• The Role of Sensory Fiber Demography in Trigeminal and Postherpetic Neuralgias

  2012cited by this paper
• Peroxisome proliferating activating receptor gamma-independent attenuation of interleukin 6 and interleukin 8 secretion from primary endometrial stromal cells by thiazolidinediones.

  2012cited by this paper
• Changes of Peroxisome Proliferator-Activated Receptor-γ on Crushed Rat Sciatic Nerves and Differentiated Primary Schwann Cells

  2012cited by this paper
• Peroxisome proliferator-activated receptor β/δ agonist GW0742 ameliorates cerulein- and taurocholate-induced acute pancreatitis in mice.

  2012cited by this paper
• Retinoid X Receptor Agonists Impair Arterial Mononuclear Cell Recruitment through Peroxisome Proliferator-Activated Receptor-γ Activation

  2012cited by this paper
• Full and partial peroxisome proliferation-activated receptor-γ agonists, but not δ agonist, rescue of dopaminergic neurons in the 6-OHDA parkinsonian model is associated with inhibition of microglial activation and MMP expression.

  2012cited by this paper
• Pioglitazone Reduces Secondary Brain Damage after Experimental Brain Trauma by PPAR-γ-Independent Mechanisms

  2011cited by this paper
• Administration of substances to laboratory animals: routes of administration and factors to consider.

  2011cited by this paper
• Attenuation of Immune-Mediated Renal Injury by Telmisartan, an Angiotensin Receptor Blocker and a Selective PPAR-γ Activator

  2011cited by this paper
• Pan‐PPAR Agonists Based on the Resveratrol Scaffold: Biological Evaluation and Docking Studies

  2010cited by this paper
• Peroxisome proliferator-activated receptor-γ agonists suppress iNOS expression induced by LPS in rat primary Schwann cells

  2010cited by this paper
• Activation of peroxisome proliferator-activated receptor gamma in brain inhibits inflammatory pain, dorsal horn expression of Fos, and local edema.

  2010cited by this paper
• Rapid pain modulation with nuclear receptor ligands.

  2009cited by this paper
• Depression and pain.

  2009cited by this paper
• Understanding the co‐occurrence of anxiety disorders and chronic pain: state‐of‐the‐art

  2009cited by this paper
• PPAR and Pain.

  2009cited by this paper
• Expression of peroxisome proliferator-activated receptor-gamma in key neuronal subsets regulating glucose metabolism and energy homeostasis.

  2009cited by this paper
• Effects of coping statements on experimental pain in chronic pain patients

  2009cited by this paper
• Peroxisome Proliferator-Activated Receptor β/δ in the Brain: Facts and Hypothesis

  2008cited by this paper
• The Thiazolidinedione Pioglitazone Alters Mitochondrial Function in Human Neuron-Like Cells

  2007cited by this paper
• Anti-inflammatory actions of PPAR ligands: new insights on cellular and molecular mechanisms.

  2007cited by this paper
• Antinociceptive and antiedematogenic activities of fenofibrate, an agonist of PPAR alpha, and pioglitazone, an agonist of PPAR gamma.

  2007cited by this paper
• Thiazolidinedione Class of Peroxisome Proliferator-Activated Receptor γ Agonists Prevents Neuronal Damage, Motor Dysfunction, Myelin Loss, Neuropathic Pain, and Inflammation after Spinal Cord Injury in Adult Rats

  2007cited by this paper
• The neuropathic pain triad: neurons, immune cells and glia

  2007cited by this paper
• Rapid Broad-Spectrum Analgesia through Activation of Peroxisome Proliferator-Activated Receptor-α

  2006cited by this paper
• Peroxisome proliferator activated receptor gamma in colonic epithelial cells protects against experimental inflammatory bowel disease.

  2006cited by this paper
• Involvement of PPAR nuclear receptors in tissue injury and wound repair.

  2006cited by this paper
• Peroxisome Proliferator-Activated Receptors (PPARs) and related transcription factors in differentiating astrocyte cultures

  2005cited by this paper
• Effects of the PPARgamma agonist pioglitazone on lipoprotein metabolism in patients with type 2 diabetes mellitus.

  2005cited by this paper
• Pioglitazone attenuates TGF‐β1‐induction of fibronectin synthesis and its splicing variant in human mesangial cells via activation of peroxisome proliferator‐activated receptor (PPAR)γ

  2005cited by this paper
• Receptor-independent actions of PPAR thiazolidinedione agonists: is mitochondrial function the key?

  2005cited by this paper
• PPARγ‐dependent effects of conjugated linoleic acid on the human glioblastoma cell line (ADF)

  2005cited by this paper
• Expression of peroxisome proliferator-activated receptors (PPARs) and retinoic acid receptors (RXRs) in rat cortical neurons.

  2005cited by this paper
• Inhibition of cell proliferation by potential peroxisome proliferator-activated receptor (PPAR) gamma agonists and antagonists.

  2004cited by this paper
• Immunolocalization of peroxisome proliferator-activated receptors and retinoid X receptors in the adult rat CNS.

  2004cited by this paper
• Retinoid X receptors: X-ploring their (patho)physiological functions

  2004cited by this paper
• Activation of peroxisome proliferator-activated receptor alpha in rat spinal cord after peripheral noxious stimulation.

  2004cited by this paper
• Brainstem mechanisms of persistent pain following injury.

  2004cited by this paper
• Rosiglitazone, a ligand of the peroxisome proliferator-activated receptor-gamma, reduces acute inflammation.

  2004cited by this paper
• The mechanisms of action of PPARs.

  2002cited by this paper
• The peroxisome proliferator-activated receptor alpha-selective activator ciprofibrate upregulates expression of genes encoding fatty acid oxidation and ketogenesis enzymes in rat brain.

  2002cited by this paper
• The role of PPAR-gamma in macrophage differentiation and cholesterol uptake.

  2001cited by this paper
• Peroxisome proliferator-activated receptor gamma and metabolic disease.

  2001cited by this paper
• Inflammatory mechanisms in Alzheimer's disease: inhibition of beta-amyloid-stimulated proinflammatory responses and neurotoxicity by PPARgamma agonists.

  2000cited by this paper
• Acute and chronic craniofacial pain: brainstem mechanisms of nociceptive transmission and neuroplasticity, and their clinical correlates.

  2000cited by this paper
• Chronic effects of lovastatin and bezafibrate on cortical and medullary hemodynamics in deoxycorticosterone acetate-salt hypertensive mice.

  1999cited by this paper
• Dental noxious input reaches the subnucleus caudalis of the trigeminal complex in the rat, as shown by c-fos expression upon thermal or mechanical stimulation.

  1994cited by this paper
• Quantitative assessment of tactile allodynia in the rat paw.

  1994cited by this paper

• PPARγ activation attenuates neonatal CRD-induced visceral pain sensitization and anxiety in male rats by alleviating oxidative stress

  2025cites this paper
• Metabolic resilience governs sex-specific pain recovery during hormonal aging: a multi-omics study of neuropathy in mice

  2025cites this paper
• Key role of PPAR-γ-mediated suppression of the NFκB signaling pathway in rutin's antidepressant effect.

  2024cites this paper
• Rapid Generation and Molecular Docking Analysis of Single-Chain Fragment Variable (scFv) Antibody Selected by Ribosome Display Targeting Cholecystokinin B Receptor (CCK-BR) for Reduction of Chronic Neuropathic Pain

  2023cites this paper
• Expression of Cannabinoid Receptors in the Trigeminal Ganglion of the Horse

  2023cites this paper
• Emodin alleviates chronic constriction injury-induced neuropathic pain and inflammation via modulating PPAR-gamma pathway

  2023cites this paper
• Characterization of pain-related behaviors and gene expression profiling of peripheral sensory ganglia in a mouse model of acute ankle sprain

  2023cites this paper
• A network pharmacology approach to predict potential targets and mechanisms of “Ramulus Cinnamomi (cassiae) – Paeonia lactiflora” herb pair in the treatment of chronic pain with comorbid anxiety and depression

  2022cites this paper
• Anti-arthritis Effects of Zingiberaceae Extracts on Models of Inflammatory Joint Disease

  2022cites this paper
• Peroxisome proliferator-activated receptor gamma agonist ELB00824 suppresses oxaliplatin-induced pain, neuronal hypersensitivity, and oxidative stress

  2022cites this paper
• Safety of cannabis- and hemp-derived constituents in reproduction and development

  2022cites this paper
• Peroxisome proliferator-activated receptor-gamma (PPARγ) and its immunomodulation function: current understanding and future therapeutic implications

  2022cites this paper
• Pre-emptive PPAR-γ Activation Abolishes Development of Nerve Injury-induced Behavioral Hypersensitivity: Elucidating Underlying Mechanisms

  2021influential citation
• The role of PPARγ in chemotherapy-evoked pain.

  2021cites this paper
• Potential Molecular Targets for Treating Neuropathic Orofacial Pain Based on Current Findings in Animal Models

  2021influential citation
• The Neuroimmunology of Chronic Pain: From Rodents to Humans

  2020cites this paper
• Propofol ameliorates neuropathic pain and neuroinflammation through PPAR γ up-regulation to block Wnt/β-catenin pathway

  2020cites this paper
• PPARγ activation mitigates mechanical allodynia in paclitaxel-induced neuropathic pain via induction of Nrf2/HO-1 signaling pathway.

  2020cites this paper
• Building and Testing PPARγ Therapeutic ELB00824 with an Improved Therapeutic Window for Neuropathic Pain

  2020cites this paper
• Pharmacological Treatment of Chemotherapy-Induced Neuropathic Pain: PPARγ Agonists as a Promising Tool

  2019cites this paper
• Sustained relief of trigeminal neuropathic pain by a blood–brain barrier penetrable PPAR gamma agonist

  2019cites this paper
• PPARs and pain

  2018cites this paper
• Új irányok a daganatellenes kezelés indukálta szenzoros neuropathiák kezelésében

  2018cites this paper
• Beyond symptomatic relief for chemotherapy‐induced peripheral neuropathy: Targeting the source

  2018cites this paper
• Combination Drug Therapy of Pioglitazone and D-cycloserine Attenuates Chronic Orofacial Neuropathic Pain and Anxiety by Improving Mitochondrial Function Following Trigeminal Nerve Injury

  2017cites this paper